<DOC>
	<DOCNO>NCT00261131</DOCNO>
	<brief_summary>The study propose determine injection BTX-A hamstring muscle result measurable physiologic change observe normal saline injection child spastic diplegic cerebral palsy walk flexed-knee gait pattern .</brief_summary>
	<brief_title>Efficacy Functional Outcomes Botulinum Toxin A Injections Hamstrings Flexed Knee Gait Cerebral Palsy</brief_title>
	<detailed_description>This study propose : ( 1 ) determine injection BTX-A hamstring muscle result measurable physiologic ( body structure body function ) change observe normal saline injection , child spastic diplegic CP walk flexed-knee gait pattern ; ( 2 ) ass whether physiologic change translate functional ( activity participation ) improvement ; ( 3 ) evaluate family 's perception change function , activity , participation , quality life . This study demonstrate BTX-A injected overactive hamstring muscle child spastic cerebral palsy ( CP ) flexed-knee walk pattern measurable effect across spectrum dimension disablement International Classification Functioning , Disability , Health ( ICF ) . It multi-center , prospective , randomize , double-blind trial compare result injection BTX- A placebo saline control , overactive hamstring muscle , use multiple outcome measure . Temporal-spatial gait parameter , instrument 3DGA kinematics , passive ROM , spasticity measurement Ashworth Tardieu scale , muscle strength/control , Gross Motor Function Measurement ( GMFM ) , Pediatric Outcomes Data Collection Instrument ( PODCI ) , Gillette Functional Assessment Questionnaire ( FAQ ) , 6-Minute Walk Test , Goal Attainment Scale ( GAS ) , assess ICF domain , collect baseline 1 month , 3 month , 6 month post-injection . Power analysis demonstrates need randomize 250 child ( 125 BTX-A , 125 saline ) , allow attrition . Nine participate hospital contribute patient .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>1 . Spastic cerebral palsy ; 2 . Bilateral low extremity involvement ; 3 . Spasticity present hamstring ; 4 . Flexed knee gait &gt; 15 degree observation ( OGS ) ; 5 . Age 3 18 year old ; ( 6 . GMFCS Level I Level IV ; ( 7 . Able walk minimum 4 complete step without rest without braces/shoes minimum 3 time ; 8 . Able follow simple command ; 9 . Cooperative physician therapist ; 10 . Able tolerate application equipment skin . 1 . Rhizotomy surgery within last 1 year ; 2 . Lower extremity surgical procedure ( soft tissue bony ) within past 1 year ; 3 . Currently implant operate Intrathecal Baclofen Pump ( oral baclofen OK ) ; 4 . Lower extremity BTXA injection within past 6 month ; 5 . Multilevel BTXA injection ; 6 . Gait trainer reliance ; 7 . Serial cast 3 month prior study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>cerebral palsy</keyword>
	<keyword>spasticity</keyword>
	<keyword>diplegia</keyword>
</DOC>